(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.14%) $78.37
(1.09%) $2.22
(-0.37%) $2 322.50
(-0.49%) $27.48
(2.39%) $988.00
(0.18%) $0.930
(0.63%) $10.89
(0.42%) $0.799
(0.19%) $91.52
2 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 4.94%
Live Chart Being Loaded With Signals
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally...
Stats | |
---|---|
本日の出来高 | 473 892 |
平均出来高 | 541 383 |
時価総額 | 12.13B |
EPS | $0 ( 2024-02-28 ) |
次の収益日 | ( $2.05 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 25.63 |
ATR14 | $0.130 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Pease Flavia | Sell | 893 | Common Stock |
2024-01-29 | Creamer Victoria L | Buy | 2 934 | Common Stock |
2024-01-29 | Creamer Victoria L | Sell | 924 | Common Stock |
2024-01-29 | Foster James C | Buy | 23 741 | Common Stock |
2024-01-29 | Foster James C | Sell | 10 540 | Common Stock |
INSIDER POWER |
---|
-0.49 |
Last 100 transactions |
Buy: 164 068 | Sell: 161 687 |
ボリューム 相関
Charles River 相関
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Charles River 相関 - 通貨/商品
Charles River 財務諸表
Annual | 2023 |
収益: | $4.13B |
総利益: | $1.50B (36.39 %) |
EPS: | $9.27 |
FY | 2023 |
収益: | $4.13B |
総利益: | $1.50B (36.39 %) |
EPS: | $9.27 |
FY | 2022 |
収益: | $3.98B |
総利益: | $1.46B (36.79 %) |
EPS: | $9.57 |
FY | 2021 |
収益: | $3.54B |
総利益: | $1.33B (37.70 %) |
EPS: | $7.77 |
Financial Reports:
No articles found.
Charles River
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。